Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway
出版年份 2021 全文链接
标题
Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway
作者
关键词
Resveratrol, Toxoplasma gondii, Inflammation, Liver injury, HMGB1/TLR4/NF-κB
出版物
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 910, Issue -, Pages 174497
出版商
Elsevier BV
发表日期
2021-09-09
DOI
10.1016/j.ejphar.2021.174497
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis
- (2021) Xiaohua Li et al. Balkan Medical Journal
- Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways
- (2020) Jia-Hui Cheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Isochlorogenic Acid A Attenuates the Progression of Liver Fibrosis Through Regulating HMGB1/TLR4/NF-κB Signaling Pathway
- (2020) Xin Liu et al. Frontiers in Pharmacology
- Antidepressive Effect of Arctiin by Attenuating Neuroinflammation via HMGB1/TLR4- and TNF-α/TNFR1-Mediated NF-κB Activation
- (2020) Xiang Xu et al. ACS Chemical Neuroscience
- Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway
- (2020) Yu-Nan Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB pathways
- (2020) Xiang Xu et al. BRITISH JOURNAL OF PHARMACOLOGY
- HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65/miR-146b Signaling
- (2020) Shanfei Ge et al. DNA AND CELL BIOLOGY
- Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway
- (2019) Xiang Xu et al. Journal of Ginseng Research
- Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
- (2019) Yam Nath Paudel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation
- (2019) Jiawen Zheng et al. Marine Drugs
- Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice
- (2019) Xujie Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening
- (2019) Yu Deng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
- (2018) Diego de Sá Coutinho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Congenital toxoplasmosis: An overview of the neurological and ocular manifestations
- (2018) Wajihullah Khan et al. PARASITOLOGY INTERNATIONAL
- Toxoplasma gondii
- (2018) Joshua A. Kochanowsky et al. CURRENT BIOLOGY
- The direct and indirect inhibition effects of resveratrol against Toxoplasma gondii tachyzoites in vitro
- (2018) Qi-Wei Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study
- (2018) Jiaofeng Huang et al. BMC INFECTIOUS DISEASES
- Could Araucaria heterophylla resin extract be used as a new treatment for toxoplasmosis?
- (2018) Nora L. El-Tantawy et al. EXPERIMENTAL PARASITOLOGY
- Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis
- (2018) Chongshan Dai et al. Cell Death & Disease
- Drug Resistance in Toxoplasma gondii
- (2018) Mahbobeh Montazeri et al. Frontiers in Microbiology
- The polysaccharide from Inonotus obliquus protects mice from Toxoplasma gondii-induced liver injury
- (2018) Lu Xu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells
- (2018) Ying Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Role of Resveratrol in Cancer Therapy
- (2017) Jeong-Hyeon Ko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Observations on bradyzoite biology
- (2017) Vincent Tu et al. MICROBES AND INFECTION
- Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells
- (2017) Zhi Hong Zhang et al. PHYTOTHERAPY RESEARCH
- Drugs in development for toxoplasmosis: advances, challenges, and current status
- (2017) Holland Alday et al. Drug Design Development and Therapy
- Antioxidant effects of resveratrol in the cardiovascular system
- (2016) Ning Xia et al. BRITISH JOURNAL OF PHARMACOLOGY
- Trillin Reduces Liver Chronic Inflammation and Fibrosis in Carbon Tetrachloride (CCl4) Induced Liver Injury in Mice
- (2016) Huabing Tan et al. IMMUNOLOGICAL INVESTIGATIONS
- Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo
- (2016) Diao He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway
- (2016) XUEQIANG JIANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii
- (2016) Nathieli B. Bottari et al. MICROBIAL PATHOGENESIS
- The molecular targets of resveratrol
- (2015) Sameer S. Kulkarni et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathological changes in acute experimental toxoplasmosis with Toxoplasma gondii strains obtained from human cases of congenital disease
- (2015) Breno Veloso Pinheiro et al. EXPERIMENTAL PARASITOLOGY
- Severe Toxoplasmic Hepatitis in an Immunocompetent Patient
- (2015) Aynur ATİLLA et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Nitric oxide in liver diseases
- (2015) Yasuko Iwakiri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii
- (2014) Yanhua Wang et al. Parasites & Vectors
- Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden
- (2012) Yinon Shapira et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine
- (2011) H. Khalili et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer
- (2011) Christian Liedtke et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation
- (2010) Stefan Bereswill et al. PLoS One
- Targeting HMGB1 in inflammation
- (2009) Huan Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
- (2009) Georgios Pappas et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Resveratrol bioavailability and toxicity in humans
- (2009) Charles-Henry Cottart et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The IKK Complex, a Central Regulator of NF- B Activation
- (2009) A. Israel Cold Spring Harbor Perspectives in Biology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started